Generics

Coronavirus News Roundup: Vaccine Trials Gaining Momentum, Pharmacists Fight Racism Amid COVID-19

June 26, 2020

Check out this week's most important coronavirus-related news.

Demand for Generic Steroid Spikes After Preliminary COVID-19 Results

June 25, 2020

Demand for an affordable generic steroid soared after preliminary findings from a study showed it may be effective in reducing deaths from the coronavirus disease 2019 (COVID-19).

Study: Patient Perceptions of Safety, Efficacy Not Swayed by Generic Drug Appearances

June 12, 2020

Survey respondents contradicted prior research that has suggested that manufacturer changes in medication appearance affect perceptions of safety and effectiveness.

ASCO20: Switching to Generic Bortezomib Can Yield Significant Cost Savings

June 03, 2020

The study’s authors examined the opportunity to decrease the overall cost of bortezomib by $300-400 million by switching patients to the generic version.

Barriers Coming Down for Complex Generic Drug Products

April 14, 2020

This year may mark a dramatic difference in the development and approval of complex generic drug products.

Generic Ziprasidone Mesylate for Injection Now Available in United States

March 18, 2020

Dr. Reddy’s Laboratories has launched its ziprasidone mesylate 20 mg/mL for injection, the first generic version of Geodon (Pfizer) for injection. 

California Considering Its Own Generic Drug Label

January 29, 2020

A pharmacy group is taking a wait-and-see approach after California Governor Gavin Newsom (D) announced several drug reforms–including a state generic prescription drug label.

Medicare Prescription Plans May Take Longer to Cover New Generic Drugs

December 05, 2019

Pharmacists can help advocate for availability and coverage.

x